| John Burns, | |
|
751 Ne Woods Chapel Rd, Lees Summit, MO 64064-1993 | |
| (816) 524-8840 | |
| Not Available |
| Full Name | John Burns |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 751 Ne Woods Chapel Rd, Lees Summit, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174927636 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 044556 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Burns, 751 Ne Woods Chapel Rd, Lees Summit, MO 64064-1993 Ph: (816) 524-8840 | John Burns, 751 Ne Woods Chapel Rd, Lees Summit, MO 64064-1993 Ph: (816) 524-8840 |
News Archive
This Wednesday the Food and Drug Administration (FDA) released guidelines regarding agency approval for certain types of new products to be obtained by tobacco-product makers. FDA announced that products such as cigarettes, roll-your-own tobacco and smokeless products that were introduced or changed after Feb. 15, 2007 must be reviewed by the agency to show that they are "substantially equivalent" to products commercially available on Feb. 15, 2007.
"Meaningful biogenerics legislation should be the first stop for policymakers tasked with financing health reform. PCMA and a broad coalition of consumers, employers, labor unions, and others support bipartisan legislation that would create a regulatory pathway for the Food and Drug Administration to approve generic versions of biologic products."
A new blood test could enable doctors to rule out tuberculosis (TB) infection within days rather than weeks, according to a new study published this week in the journal Annals of Internal Medicine.
Octapharma confirmed today the European Medicines Agency (EMA) has adopted a positive opinion towards human cell line recombinant human FVIII, Nuwiq®, recommending the granting of a marketing authorisation for the medicinal product for treatment and prophylaxis of bleeding (also during and after surgery) in paediatric and adult patients with haemophilia A (congenital FVIII deficiency).
Survival rates among HIV-positive people who undergo routine viral load and CD4+ T cell counts were nearly the same as those who do not receive the tests, according to a study published on Friday in the journal Lancet, the CP/Google.com reports (CP/Google.com, 4/24).
› Verified 9 days ago
David Wilson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 348 Nw Capital Dr, Lees Summit, MO 64086 Phone: 816-600-2200 | |
Shaun Sousley, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Ne Sam Walton Ln, Lees Summit, MO 64086 Phone: 816-525-2750 | |
Douglas Klein, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1198 Ne Douglas St, Lees Summit, MO 64086 Phone: 816-607-5152 | |
Michael J. Dieker, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 924 Ne Michael Dr, Lees Summit, MO 64086 Phone: 816-525-2529 | |
Michala Foster, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Ne Sycamore St # A, Lees Summit, MO 64086 Phone: 816-246-4222 Fax: 816-246-4223 | |
Heather Marie Maruska, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1850 Nw Chipman Rd, Lees Summit, MO 64081 Phone: 816-524-1753 | |
Mr. Mannie Trujillo, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Ne Sam Walton Ln, Lees Summit, MO 64086 Phone: 214-673-0941 |